13 results on '"Hansen, Doris"'
Search Results
2. BCMA-directed CART therapy in patients with multiple myeloma and CNS involvement.
3. Reply to R. Chakraborty et al
4. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium
5. Idecabtagene vicleucel (Ide-cel) chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory multiple myeloma (RRMM): Real-world experience.
6. Clinical presentation and outcome of patients with AL amyloidosis requiring salvage therapy.
7. Impact of doxycycline on outcomes in AL amyloidosis.
8. Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?
9. Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.
10. Experience of a stem cell transplant in multiple myeloma: The patient and care partner perspective.
11. Impact of bridging therapy (BT) on outcome of relapsed refractory multiple myeloma (RRMM) with Ide-cel CAR T-cell therapy: Real-world experience from the US myeloma CAR T consortium.
12. Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).
13. Association of frailty and high-risk immuno-nutritional score with outcomes in patients with relapsed and refractory multiple myeloma treated with chimeric antigen receptor T-cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.